newsfilter
← Latest News
PR Newswire·

The RD Fund Announces Ocuphire Pharma's Acquisition of Opus Genetics

The RD Fund (Retinal Degeneration Fund) – the venture arm of the Foundation Fighting Blindness – announces the all-stock acquisition of Opus...